Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Merck emerges as lead bidder in potential Acceleron buyout with deal possible this week — report
Endpoints
Tue, 09/28/21 - 12:15 am
Merck
Acceleron
M&A
PAH
sotatercept
Rumor mill says Acceleron is speeding towards $11bn sale
Pharmaforum
Sun, 09/26/21 - 11:28 pm
Acceleron
M&A
Is Boston Sci’s Latest M&A a Sign the Thrombectomy Space is Heating Up?
Medical Devices and Diagnostics Industry
Tue, 09/21/21 - 10:55 pm
devices
Boston Scientific
Devoro Medical
M&A
thrombectomy
Boehringer Ingelheim acquires Abexxa Biologics
Biopharma Reporter
Tue, 09/21/21 - 10:56 am
Boehringer Ingelheim
M&A
Abexxa Biologics
cancer
antibodies
drug development
Repligen sees $150M Avitide acquisition as key to reaching gene therapy goals
MedCity News
Mon, 09/20/21 - 12:06 am
Repligen
Avitide
biologics
M&A
Flywheel raises $22M, buys competitor
MedCity News
Thu, 09/16/21 - 10:45 am
clinical trials
Flywheel
Radiologics
M&A
AbbVie dodges hedge fund lawsuit over failed $55B Shire pursuit
Fierce Pharma
Tue, 09/14/21 - 10:34 pm
AbbVie
Shire
hedge funds
M&A
Pfizer and Trillium: How a $25M investment led to a $2.3B buyout
Fierce Biotech
Tue, 09/14/21 - 10:52 am
Pfizer
Trillium Therapeutics
M&A
AzurRx to acquire First Wave Bio for $229m
Pharmaceutical Business Review
Tue, 09/14/21 - 10:50 am
M&A
AzurRx BioPharma
First Wave Bio
Zoll Strengthens Position in Sleep Apnea Market with Acquisition
Medical Devices and Diagnostics Industry
Mon, 09/13/21 - 10:22 am
ZOLL Medical
M&A
sleep apnea
Itamar Medical
devices
Bone mulls a trade sale
EP Vantage
Fri, 09/10/21 - 10:28 am
Bone Therapeutics
JTA-004
Hybrigenics
M&A
cell therapy
Sanofi acquires Kadmon for $1.9 billion, adding transplant medicine drug
Stat
Wed, 09/8/21 - 12:01 pm
Sanofi
Kadmon
M&A
transplant medicine
graft vs host disease
As Forte fails, who might yet improve the image of reverse mergers?
EP Vantage
Wed, 09/8/21 - 11:04 am
reverse merger
M&A
Forte Biosciences
Tocagen
Hybrigenics says it wants a merger with Bone Therapeutics
Pharmaforum
Tue, 09/7/21 - 11:02 am
M&A
Bone Therapeutics
Hybrigenics
regenerative medicine
Sobi agrees $8bn takeover offer from Advent and GIC
Pharmaceutical Business Review
Fri, 09/3/21 - 10:59 am
Sobi
M&A
Advent International
GIC
Boston Scientific completes $1.1B Lumenis acquisition
Mass Device
Thu, 09/2/21 - 09:41 pm
devices
M&A
Boston Scientific
Lumenis
Sanofi refiles $3.2B Translate Bio buyout with FTC to allow more time for review
Fierce Pharma
Tue, 08/31/21 - 10:06 pm
Sanofi
Translate Bio
M&A
FTC
Is Baxter in Advanced Talks to Acquire Hill-Rom for $10B?
Medical Devices and Diagnostics Industry
Mon, 08/30/21 - 11:40 pm
Baxter
Hill-Rom
M&A
devices
In $1B buyout, Catalent takes on gummy company to jump into a booming market
Endpoints
Mon, 08/30/21 - 11:01 am
Catalent
CDMOs
Bettera
M&A
[podcast]Diving into Medtech's M&A in 2021
Medical Devices and Diagnostics Industry
Thu, 08/26/21 - 08:39 pm
devices
Medtech
M&A
Pages
« first
‹ previous
…
37
38
39
40
41
42
43
44
45
…
next ›
last »